144 related articles for article (PubMed ID: 38040318)
1. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis.
Luo H; Chen X; Jiang Z; Yan Q
Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318
[TBL] [Abstract][Full Text] [Related]
2. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis.
Willems RPJ; van Dijk K; Vehreschild MJGT; Biehl LM; Ket JCF; Remmelzwaal S; Vandenbroucke-Grauls CMJE
Lancet Infect Dis; 2023 Jun; 23(6):719-731. PubMed ID: 36731484
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
Fang C; Zhou Z; Zhou M; Li J
Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):66. PubMed ID: 37537568
[TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
[TBL] [Abstract][Full Text] [Related]
5. ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery.
Righi E; Mutters NT; Guirao X; Del Toro MD; Eckmann C; Friedrich AW; Giannella M; Kluytmans J; Presterl E; Christaki E; Cross ELA; Visentin A; Sganga G; Tsioutis C; Tacconelli E
Clin Microbiol Infect; 2023 Apr; 29(4):463-479. PubMed ID: 36566836
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU.
Tsai MH; Chu SM; Hsu JF; Lien R; Huang HR; Chiang MC; Fu RH; Lee CW; Huang YC
Pediatrics; 2014 Feb; 133(2):e322-9. PubMed ID: 24420803
[TBL] [Abstract][Full Text] [Related]
7. Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Gram-Negative Pathogens in Makkah, Saudi Arabia.
Kabrah A
Ethiop J Health Sci; 2022 Nov; 32(6):1221-1230. PubMed ID: 36475249
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
Chayakulkeeree M; Junsriwong P; Keerasuntonpong A; Tribuddharat C; Thamlikitkul V
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1503-9. PubMed ID: 16610653
[TBL] [Abstract][Full Text] [Related]
9. Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections.
Zhen S; Wang H; Feng S
Infection; 2022 Dec; 50(6):1409-1423. PubMed ID: 35781869
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J
Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028
[TBL] [Abstract][Full Text] [Related]
11. Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study.
Kömürcü B; Tükenmez Tigen E; Toptaş T; Fıratlı Tuğlular T; Korten V
Expert Rev Hematol; 2020 Aug; 13(8):923-927. PubMed ID: 32574123
[TBL] [Abstract][Full Text] [Related]
12. Transmission of multidrug-resistant Gram-negative bacteria from colonized mothers to their infants: a systematic review and meta-analysis.
Bulabula ANH; Dramowski A; Mehtar S
J Hosp Infect; 2020 Jan; 104(1):57-67. PubMed ID: 31604126
[TBL] [Abstract][Full Text] [Related]
13. The Increasing Challenge of Multidrug-Resistant Gram-Negative Bacilli: Results of a 5-Year Active Surveillance Program in a Neonatal Intensive Care Unit.
Giuffrè M; Geraci DM; Bonura C; Saporito L; Graziano G; Insinga V; Aleo A; Vecchio D; Mammina C
Medicine (Baltimore); 2016 Mar; 95(10):e3016. PubMed ID: 26962817
[TBL] [Abstract][Full Text] [Related]
14. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
[TBL] [Abstract][Full Text] [Related]
15. Bloodstream infections due to Gram-negative bacteria in patients with hematologic malignancies: updated epidemiology and risk factors for multidrug-resistant strains in an Italian perspective survey.
Trecarichi EM; Giuliano G; Cattaneo C; Ballanti S; Criscuolo M; Candoni A; Marchesi F; Laurino M; Dargenio M; Fanci R; Cefalo M; Delia M; Spolzino A; Maracci L; Bonuomo V; Busca A; Principe MID; Daffini R; Simonetti E; Dragonetti G; Zannier ME; Pagano L; Tumbarello M;
Int J Antimicrob Agents; 2023 Jun; 61(6):106806. PubMed ID: 37030470
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance and extended-spectrum beta-lactamase producing Gram-negative bacteria from three Referral Hospitals of Amhara region, Ethiopia.
Moges F; Gizachew M; Dagnew M; Amare A; Sharew B; Eshetie S; Abebe W; Million Y; Feleke T; Tiruneh M
Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):16. PubMed ID: 33706775
[TBL] [Abstract][Full Text] [Related]
17. Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections.
Kanj SS; Bassetti M; Kiratisin P; Rodrigues C; Villegas MV; Yu Y; van Duin D
Int J Antimicrob Agents; 2022 Sep; 60(3):106633. PubMed ID: 35787918
[TBL] [Abstract][Full Text] [Related]
18. High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis.
Tufa TB; Fuchs A; Tufa TB; Stötter L; Kaasch AJ; Feldt T; Häussinger D; Mackenzie CR
Antimicrob Resist Infect Control; 2020 Aug; 9(1):128. PubMed ID: 32771059
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia.
Beyene D; Bitew A; Fantew S; Mihret A; Evans M
PLoS One; 2019; 14(9):e0222911. PubMed ID: 31553773
[TBL] [Abstract][Full Text] [Related]
20. Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study.
Tacconelli E; Górska A; De Angelis G; Lammens C; Restuccia G; Schrenzel J; Huson DH; Carević B; Preoţescu L; Carmeli Y; Kazma M; Spanu T; Carrara E; Malhotra-Kumar S; Gladstone BP
Clin Microbiol Infect; 2020 Jan; 26(1):87-94. PubMed ID: 31128285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
